Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2012
10/04/2012WO2012135589A1 Methods of administering beta7 integrin antagonists
10/04/2012WO2012135408A1 Stable formulations of antibodies to human programmed death receptor pd-1 and related treatments
10/04/2012WO2012135360A1 Binding proteins specific for egfr expressed on tumor and uses thereof
10/04/2012WO2012135332A1 Modulators of plexin b2 activity
10/04/2012WO2012135313A1 Compositions and methods for detecting allergy to a-gal epitopes
10/04/2012WO2012135177A2 Methods and compositions for cytomegalovirus il-10 protein
10/04/2012WO2012135132A1 Compositions and methods to immunize against hepatitis c virus
10/04/2012WO2012135035A1 Anti - sclerostin antibody crystals and formulations thereof
10/04/2012WO2012134975A1 Methods and compositions employing immunogenic fusion proteins
10/04/2012WO2012134925A1 Heterobifunctional esters for use in labeling target molecules
10/04/2012WO2012134591A2 Plasmodium falciparum antigens
10/04/2012WO2012134039A1 Protein having antigen activity against liver flukes
10/04/2012WO2012133914A1 Potentiator of cancer immunity containing rankl antagonist
10/04/2012WO2012133814A1 Therapeutic agent for cancer, and method for determining prognosis of cancer
10/04/2012WO2012133782A1 Retention of antigen-binding molecules in blood plasma and method for modifying immunogenicity
10/04/2012WO2012133735A1 Nucleic acid construct containing nucleic acid derived from genotype 1b hcv genome, hcv genome-replicating cells transfected with same, and method for producing infectious hcv particles
10/04/2012WO2012132067A1 Retention of antigen-binding molecules in blood plasma and method for modifying immunogenicity
10/04/2012WO2012131580A1 Method of detecting chikungunya virus utilizing a recombinant el coat peptide antigen
10/04/2012WO2012131504A1 Pcsk9 vaccine
10/04/2012WO2012131128A1 Diva method for differentiating animals vaccinated against brucellosis
10/04/2012WO2012131099A1 Use of blood or tissue bacteriome for prediction, diagnosis and prevention of metabolic diseases and their cardiovascular complications
10/04/2012WO2012131066A1 Vaccine against pasteurellaceae
10/04/2012WO2012131053A1 Methods of treating immune disorders with single domain antibodies against tnf-alpha
10/04/2012WO2012130970A1 Natural derivative of the lactobacillus johnsonii strain cncm i-1225 deficient in d-lactic acid production
10/04/2012WO2012130968A1 Natural derivative of the lactobacilus johnsonii strain cncm i-1225, deficient in d-lactic acid production and with a further improved immune profile
10/04/2012WO2012130966A1 Derivative of the lactobacilus johnsonii strain cncm i-1225, deficient in d-lactic acid production and with an improved shelf life
10/04/2012WO2012130965A1 Natural derivative of a well known and successful probiotic strain deficient in d-lactic acid production
10/04/2012WO2012130723A1 Salmonid alphavirus vaccine
10/04/2012WO2012130165A1 Liver cancer diagnosis marker and use thereof
10/04/2012WO2012130141A1 Method and composition for enhancing target cells uptake of therapeutic agents
10/04/2012WO2012129872A1 Biological product and method of preparing same
10/04/2012WO2012129668A1 Antibodies against kidney associated antigen 1 and antigen binding fragments thereof
10/04/2012WO2012129645A1 Non-pathogenic serotype 4 fowl adenovirus (fadv-4) and viral vector thereof
10/04/2012WO2012109464A3 Modified peptide that reduces pain in peripheral neuropathy
10/04/2012WO2012109285A3 Antibodies that specifically bind staphylococcus aureus alpha toxin and methods of use
10/04/2012WO2012109282A3 Methods and systems for treating or preventing pregnancy-related hypertensive disorders
10/04/2012WO2012106368A9 Methods for inhibiting prostate cancer
10/04/2012WO2012083445A8 Virus like particle production in plants
10/04/2012WO2012081947A3 Vaccine for inducing an improved immune reaction
10/04/2012WO2012075422A3 Compositions and methods for treating amyloid plaque associated symptoms
10/04/2012WO2010127172A3 Chimeric factor h binding proteins (fhbp) and methods of use
10/04/2012WO2006089690A9 Use of a modified poxvirus for the rapid induction of immunity against a poxvirus or other infectious agents
10/04/2012US20120253191 Porphyrin nanovesicles
10/04/2012US20120253019 Novel monoclonal thyroid stimulating or blocking antibodies, peptide sequences corresponding to their variable regions, and their uses in diagnostic, preventive and therapeutic medicine
10/04/2012US20120252846 Buccal, polar and non-polar spray or capsule containing drugs for treating pain
10/04/2012US20120252732 Albumin fusion proteins
10/04/2012US20120252097 Therapeutic Agents Comprising Pro-Apoptotic Proteins
10/04/2012US20120251586 Ligand-specific inhibition of attachment of immune cells to implantable biomaterials
10/04/2012US20120251584 Combination pharmaceutical composition and methods of treating diseases or conditions associated with the cardiovascular system
10/04/2012US20120251580 Methods of use for a natural thomsen-friedenreich disaccharide compound
10/04/2012US20120251579 Compositions for generating an antigen specific immune response
10/04/2012US20120251578 Diagnostic, Therapeutic And A Vaccine Against Treponemes
10/04/2012US20120251577 Selectively disrupted whole-cell vaccine
10/04/2012US20120251576 Treatment of Nasal and Sinus Disorders
10/04/2012US20120251575 Endopeptidase Treatment of Involuntary Movement Disorders
10/04/2012US20120251574 Endopeptidase and Neurotoxin Combination Treatment of Multiple Medical Conditions
10/04/2012US20120251573 Endopeptidase Treatment of Neuroendocrine Disorders
10/04/2012US20120251572 Hepatitis c virus vaccine composition
10/04/2012US20120251570 Method, kit, plasmid and composition for inducing an immune response to dengue virus, on the basis of dna and chimeric virus vaccines
10/04/2012US20120251569 Composition for treating hbv infection
10/04/2012US20120251568 Recombinant influenza viruses and uses thereof
10/04/2012US20120251566 Saponin adjuvant compositions and methods relating thereto
10/04/2012US20120251565 Compositions and methods for preventing or treating burkholderia infection
10/04/2012US20120251564 Reovirus compositions and methods of use
10/04/2012US20120251563 Modulation of immune response by non-peptide binding stress response polypeptides
10/04/2012US20120251562 Inhibitors of the PP1/GADD34 Complex for the Treatment of a Condition Requiring an Immunosuppressive Activity
10/04/2012US20120251561 Administration of dendritic cells partially matured in vitro for the treatment of tumors
10/04/2012US20120251560 Conjugated lipomers and uses thereof
10/04/2012US20120251559 Treatment of B-Cell Cancers With Anti-CD70 Antibody-Drug Conjugates
10/04/2012US20120251558 Antibody-drug conjugates
10/04/2012US20120251557 GalNAc-SPECIFIC BINDING MOLECULES AND USES THEREOF
10/04/2012US20120251556 Combination Immunotherapy for the Treatment of Cancer
10/04/2012US20120251555 Antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen and uses thereof
10/04/2012US20120251554 Anti-cd33 antibodies and use thereof for immunotargeting in treating cd33-associated illnesses
10/04/2012US20120251553 Biomarkers for schizophrenia or other psychotic disorders
10/04/2012US20120251552 Methods of generating improved antigen-binding agents using chain shuffling and optionally somatic hypermutation
10/04/2012US20120251551 Substituted (Heteroarylmethyl)thiohydantoins
10/04/2012US20120251550 Crystalline anti-hTNFalpha antibodies
10/04/2012US20120251549 Complement inhibitors and uses thereof
10/04/2012US20120251548 Treatment of Dermatological Pathologies
10/04/2012US20120251547 Il-17 receptor a antigen binding proteins
10/04/2012US20120251546 Type 1 inteferon diagnostic
10/04/2012US20120251545 Therapeutic Combinations Of Hydroxybenzamide Derivatives As Inhibitors Of HSP90
10/04/2012US20120251544 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)
10/04/2012US20120251543 Methods and compositions for modulating apoptosis
10/04/2012US20120251542 Anti-toxin vaccine compositions and methods of use thereof
10/04/2012US20120251541 Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region Orientation
10/04/2012US20120251540 Stabilized single domain antibodies
10/04/2012US20120251539 Methods and Compositions for the Treatment of Immune Disorders
10/04/2012US20120251538 Use of fgfr1 extra cellular domain proteins to treat cancers characterized by ligand-dependent activating mutations in fgfr2
10/04/2012US20120251537 Compositions and methods for the treatment of infections and tumors
10/04/2012US20120251536 Biopolymer hybrid gel-depot delivery system
10/04/2012US20120251535 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody
10/04/2012US20120251534 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody
10/04/2012US20120251533 Monoclonal antibodies against cd30 lacking in fucosyl residues
10/04/2012US20120251532 Anti-alpha v beta 6 antibodies
10/04/2012US20120251531 ANTIBODY Fc VARIANTS
10/04/2012US20120251530 Combination therapy of her expressing tumors
10/04/2012US20120251529 Anti-cea antibodies
10/04/2012US20120251528 Non-Human Mammal Model Of Human Hematopoietic Cancer
1 ... 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 ... 1823